Hello everyone and welcome to At Barrens. I'm Andy Serwer and welcome to our guest Paul Hudson, CEO of Sanofi. Paul, nice to see you.

Great to be here. Thanks for inviting me. So Sanofi is a big French pharma company and you make prescription medicines over the counter and vaccines. What am I missing?

How else can you describe the company? Well, I would say that we reposition ourselves as a scientific

leader, perhaps going to become the world's leader in immunology. We're pioneers with AI at scale

and we're launching medicines now continuously.

It's a new CenoFi, if you like.

So your biggest products, talk to us about that, and then we'll get to the pipeline and

all that.

But what are you guys making today that drives the business?

Well, we really bring out some amazing life-changing medicines.

DuPiixen, which many of your viewers will see and have seen our

advertised on television, has changed so many lives. Almost a million lives have been changed.

People with difficult skin conditions like atopid dermatitis, difficult to treat asthma.

You know, these are really debilitating conditions and that's our biggest medicine by far.

We're in the flu business, of course, protecting people with flu.

We're in rare diseases, protecting people with rare disorders that are really difficult

challenges for them as human beings, but we're there to help them hand in hand.

And we're really, you know, doubling down on immunology to become the world's leading

immunology company. Also, insulin and yellow fever vaccines, those kinds of?

We're end to end, right? Because the way the company was created, we were all over the entire

world, almost in every country, trying to do the right thing. You mentioned yellow fever.

We just recently issued some new information around a sleeping sickness, and we're trying to advance the agenda for those that really have no alternative in these difficult disease in difficult areas.

...